Skip to main content
Clinical Trials/JPRN-UMIN000034498
JPRN-UMIN000034498
Completed
未知

Feasibility study of cancer rehabilitation during concurrent chemoradiation for cervical cancer - Cancer rehabilitation during concurrent chemoradiation for cervical cancer

Department of Obstetrics and Gynecology Kurume University0 sites20 target enrollmentOctober 15, 2018
Conditionscervical cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
cervical cancer
Sponsor
Department of Obstetrics and Gynecology Kurume University
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 15, 2018
End Date
July 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Department of Obstetrics and Gynecology Kurume University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. PS 3,4 2\. Patients who need assistance in walking 3\. Patients who have difficulty understanding instruction by language 4\. Patients with complications affecting walking 5\. Patient who is difficult to fill in questionnaire 6\. Restriction of rest by bone lesion, cases where evaluation cooperation can not be obtained due to remarkable pain 7\. Blood findings: Hb 7\.5 g/dL or less, Plt 20,000/uL or less, WBC 3,000/uL or less 8\. Invasion of more than 50% of the bone cortex, bone erosion towards the center of the bone, metastatic findings of the long bone with 3 cm or more lesions of the femur 9\. Cavity internal organs, blood vessels, compression of the spinal cord 10\. Pain, dyspnea, exudate retention in the pleura, pericardium, retroperitoneum with movement restriction 11\. Dysfunction of the central nervous system, disturbance of consciousness, hypercranial hypertension 12\. hypokalemia, hyperkalemia, hyponatremia, hypernatremia, hypocalcemia, hypercalcemia 13\. Orthostatic hypotension, hypertension of 160/100 mmHg or more 14\. Tachycardia of 110/min or more, ventricular arrhythmia

Outcomes

Primary Outcomes

Not specified

Similar Trials